Monday, June 14, 2021
Home Citizen News Explained: Moderna Covid-19 vaccine stability eases distribution challenges

Explained: Moderna Covid-19 vaccine stability eases distribution challenges

Moderna Inc’s experimental COVID-19 vaccine is more stable than expected at temperatures that ordinary refrigerators can provide and can be distributed using existing cold-chain shipping and storage infrastructure. That opens the door for its early use in hard to reach places that might not be appropriate for Pfizer Inc’s vaccine which needs ultra-cold storage. Here are details of how it could be distributed.How cold is cold storage? Moderna’s vaccine is stable for up to six months at a temperature of minus 20 degrees Celsius (-4 F), about home freezer levels, when shipped and stored.

50% LikesVS
50% Dislikes

News Verification For Headline Auditors

If this seems like a news that is relevant to your industry. Would you like to verify the authenticity of the news?
Please Enter your Secret Key

We are building a board of industry expert to help us verify important news stories. If you would like to empanel yourself, please click here.

Report Post

TRENDING NEWS

LATEST NEWS